AU476551B2 - Inhibition of leukemia utilizing 5-methyltetra-hydrohomofolate - Google Patents
Inhibition of leukemia utilizing 5-methyltetra-hydrohomofolateInfo
- Publication number
- AU476551B2 AU476551B2 AU57820/73A AU5782073A AU476551B2 AU 476551 B2 AU476551 B2 AU 476551B2 AU 57820/73 A AU57820/73 A AU 57820/73A AU 5782073 A AU5782073 A AU 5782073A AU 476551 B2 AU476551 B2 AU 476551B2
- Authority
- AU
- Australia
- Prior art keywords
- hydrohomofolate
- methyltetra
- leukemia
- inhibition
- utilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00274749A US3856959A (en) | 1972-07-24 | 1972-07-24 | Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate |
| USUS274749 | 1972-07-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5782073A AU5782073A (en) | 1975-01-09 |
| AU476551B2 true AU476551B2 (en) | 1976-09-30 |
Family
ID=23049461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU57820/73A Expired AU476551B2 (en) | 1972-07-24 | 1973-07-06 | Inhibition of leukemia utilizing 5-methyltetra-hydrohomofolate |
Country Status (11)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572137A (en) * | 1977-02-22 | 1980-07-23 | Bioresearch Sas Del Dr Livio C | Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts |
| US4927828A (en) * | 1985-03-08 | 1990-05-22 | The Trustees Of Princeton University | Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives |
| US4684653A (en) * | 1985-03-08 | 1987-08-04 | The Trustees Of Princeton University | Pyrido(2,3-d)pyrimidine derivatives |
| US5026851A (en) * | 1985-03-08 | 1991-06-25 | The Trustees Of Princeton University | Pyrido[2,3-]pyrimidine derivatives |
| US4833145A (en) * | 1986-06-30 | 1989-05-23 | The Trustees Of Princeton University | 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives |
| US4902796A (en) * | 1986-10-20 | 1990-02-20 | The Trustees Of Princeton University | 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines |
| US4818819A (en) * | 1986-10-20 | 1989-04-04 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
| US5028608A (en) * | 1989-12-11 | 1991-07-02 | The Trustees Of Princeton University | N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives |
| US9265746B2 (en) * | 2006-05-31 | 2016-02-23 | Merck & Cie | Method for cell-specific targeting |
-
1972
- 1972-07-24 US US00274749A patent/US3856959A/en not_active Expired - Lifetime
-
1973
- 1973-06-27 CA CA175,097A patent/CA1006093A/en not_active Expired
- 1973-07-06 AU AU57820/73A patent/AU476551B2/en not_active Expired
- 1973-07-09 GB GB3252873A patent/GB1442772A/en not_active Expired
- 1973-07-14 DE DE19732335898 patent/DE2335898A1/de not_active Withdrawn
- 1973-07-18 AT AT633073A patent/AT329312B/de not_active IP Right Cessation
- 1973-07-18 NL NL7309977A patent/NL7309977A/xx not_active Application Discontinuation
- 1973-07-23 FR FR7326846A patent/FR2193608B1/fr not_active Expired
- 1973-07-23 SE SE7310220A patent/SE431612B/xx unknown
- 1973-07-24 BE BE133796A patent/BE802709A/xx not_active IP Right Cessation
- 1973-07-24 JP JP8276773A patent/JPS5541207B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AT329312B (de) | 1976-05-10 |
| NL7309977A (US08063081-20111122-C00044.png) | 1974-01-28 |
| GB1442772A (en) | 1976-07-14 |
| FR2193608A1 (US08063081-20111122-C00044.png) | 1974-02-22 |
| SE431612B (sv) | 1984-02-20 |
| JPS4950113A (US08063081-20111122-C00044.png) | 1974-05-15 |
| ATA633073A (de) | 1975-07-15 |
| DE2335898A1 (de) | 1974-02-07 |
| CA1006093A (en) | 1977-03-01 |
| US3856959A (en) | 1974-12-24 |
| JPS5541207B2 (US08063081-20111122-C00044.png) | 1980-10-22 |
| BE802709A (fr) | 1973-11-16 |
| AU5782073A (en) | 1975-01-09 |
| FR2193608B1 (US08063081-20111122-C00044.png) | 1976-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU483098B2 (en) | Showerhead | |
| AU470375B2 (en) | Substituted w-pentanorprostaglandins | |
| CA1006093A (en) | Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate | |
| CA980352A (en) | Substituted aminohalopyridines | |
| CA1029734A (en) | Manufacture of benzil-monoketals | |
| AU5624873A (en) | Metal-coil lacquers | |
| AU474093B2 (en) | Chemosterilization of ixodides | |
| AU472956B2 (en) | Substituted benzodioxoles | |
| CA995680A (en) | Substituted 2-benzoyloxazolidines | |
| CA915705A (en) | Derivatives of dipropylacetylanilide | |
| CA892026A (en) | Derivatives of dibenzocycloheptenes | |
| CA904356A (en) | Synthesis of alkadienols | |
| CA891405A (en) | Decomposition inhibition | |
| CA915708A (en) | Manufacture of 2-ethylhexanal-1 | |
| AU471181B2 (en) | Manufacture of bipridyls | |
| AU458647B2 (en) | Manufacture of 6-60methylenetetracyclines | |
| AU455096B2 (en) | Manufacture of chlorofluoropyridines | |
| CA1021790A (en) | 3-substituted-iodo-alkenyl compound | |
| CA1006422A (en) | Coating of metals | |
| CA1033650A (en) | Coating of metals | |
| CA905955A (en) | Derivatives of benzodiazepine | |
| AU463195B2 (en) | Manufacture of &-6-deoxytetracyclines | |
| CA917658A (en) | Derivatives of benzodiazepines | |
| CA917657A (en) | Derivatives of benzodiazepines | |
| AU489465B2 (en) | Chemotherapeutic compositions |